Authorizing pharmacists to prescribe and dispense preexposure prophylaxis and postexposure prophylaxis for HIV prevention to patients under certain circumstances; requiring the Maryland Medical Assistance Program to provide drugs that are approved by the United States Food and Drug Administration for HIV prevention; prohibiting managed care organizations, certain insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for certain drugs for HIV prevention; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2022, January 1, 2023
HistoryToggle History Dropdown
File CodeToggle Filecode Dropdown
SubjectsToggle Subjects Dropdown
StatutesToggle Statutes Dropdown
Last Updated: 3/25/2022 3:16 PM